While Canadian cannabis stocks have been on a multi-year tear in anticipation of full legalization, U.S. cannabis stocks have lagged. And while the author of today’s article acknowledges that there are a number of good reasons why Canadian cannabis stocks deserve a premium, he argues that this premium appears to be excessive – and uses one U.S. producer and one Canadian producer to illustrate his case that U.S. cannabis stocks offer compelling relative value. For more – including some catalysts that could lie ahead for U.S. producers – CLICK HERE.